Advanced
Products
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Neurophth
Neurophth
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Neurophth
Total Funding
$60 M
Neurophth Summary
Company summary
Overview
Neurophth is a fully integrated genomic medicines company dedicated to seeking to improve lives through the curative potential of gene therapies.
Type
Private
Status
Active
Founded
2016
Website
https://www.neurophth.com/
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
life sciences
pharma
Homepage
Linkedin
Key people
Qiutang Li,
Chief Scientific Officer
Xin Zhang,
Chief Operating Officer and Chief Medical Officer
Su Xiao,
Co-founder and Chief Technology Operating Officer
Bose Kalampanayil,
Chief Technology Officer
Competitors and similar companies
Jacobio
Healthcare - Public
Boston Analytical
Healthcare - Subsidiary
Bioiberica
Healthcare - Subsidiary
Aptuit
Healthcare - Subsidiary
Compare competitors
News
Neurophth Raised Over $60 Million USD in Series-C Financing to Advance Gene Therapies
Nov 23, 2021
Report incorrect company information
Footer menu
Contact us
Facebook
Twitter
LinkedIn
Products
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Press
Company
About
Careers
Terms of Service
Privacy Policy
© Craft.co 2023
Share price data provided by IEX
Company directory
Search directory
Back
to top